Skip to main content
. Author manuscript; available in PMC: 2007 Nov 7.
Published in final edited form as: JAMA. 2005 Jul 6;294(1):81–90. doi: 10.1001/jama.294.1.81

Table 1.

Characteristics of the sickle cell disease study population.

Patient characteristic* SCD* n Controls n p**
Age (years) 36 (11) 228 37 (11) 36 .68
Alanine aminotransferase (U/L) 27 (15) 225 23 (12) 36 .14
Albumin (mg/dL) 4.1 (0.4) 224 4.1 (.2) 35 .29
Alkaline phosphatase (U/L) 115 (87) 224 78 (23) 36 .004
Aspartate aminotransferase (U/L) 41 (22) 223 24 (8) 36 < .001
Blood urea nitrogen (mg/dL) 10 (10) 225 12 (4) 36 .002
C-reactive protein (μg/mL) .57 (0.91) 203 .35 (.47) 35 .04
Creatinine (mg/dL) .71(.67,.76) 225 .88(.80,.96) 36 .02
Erythrocyte sedimentation rate (mm/h) 39 (31) 180 21 (18) 35 <.001
Gender (% female) 60 228 53 36 .44
Hematocrit (%) 28 (5) 226 41 (4) 36 < .001
Hemoglobin (g/dL) 9.5 (1.8) 226 13.7 (1.5) 36 < .001
Hemoglobin F (%) 7.4 (6.6) 227 0.4 (0.6) 33 < .001
Hemoglobin SC (%) 18 228
Lactate dehydrogenase (U/L) 347 (158) 204 166 (39) 35 < .001
Reticulocyte count (per μL) 243 (132) 214 66 (28) 33 < .001
Tricuspid regurgitant jet velocity (m/s) 2.3 (0.6) 224 1.9 (.5) 36 .002
Triglycerides (mg/dL) 116 (68) 200 79 (49) 29 < .001
Weight (kg) 71 (18) 178 84 (16) 33 < .001
White blood cell count (thousands/μL) 10.2 (3.7) 226 5.8 (2.1) 36 < .001
*

Mean (standard deviation) for continuous variables (except creatinine, for which geometric mean and 95% confidence interval are shown because of highly skewed values in sickle cell disease patients); percentage with characteristic for dichotomous variable.

**

From two-sided t-test for continuous variables (on log10 transformed values for laboratory assays); chi-square test without continuity correction for dichotomous variables.

HHS Vulnerability Disclosure